We are live on
!
Find out more
HI
HBK Investments Portfolio holdings
AUM
$9.85B
1-Year Est. Return
55.6%
This Fund
S&P 500
This Quarter
Est. Return
+2.99%
1 Year Est. Return
+55.6%
3 Year Est. Return
+156.38%
5 Year Est. Return
+423.64%
10 Year Est. Return
+2,347.17%
AUM
$25.7B
AUM Growth
-$2.83B
(-9.9%)
Cap. Flow
-$3.69B
Cap. Flow
% of AUM
-14.38%
Top 10 Holdings %
Top 10 Hldgs %
77.27%
Holding
989
New
172
Increased
119
Reduced
210
Closed
249
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$418M |
| 2 |
STMP
Stamps.com, Inc.
STMP
|
+$267M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$266M |
| 4 |
FIVE9
FIVN
|
+$175M |
| 5 |
PPD
PPD, Inc. Common Stock
PPD
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.12B |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$734M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$525M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 4.78% |
| 2 | Technology | 4.62% |
| 3 | Financials | 3.5% |
| 4 | Industrials | 3% |
| 5 | Consumer Discretionary | 1.15% |
Similar funds
MF
MPI
URS
CCM
HRCM
FCM
HL
DCP
HBK Investments's Q3 2021 Portfolio in Review
As of Q3 2021, HBK Investments held 989 positions worth $25.7B, down 9.9% from $28.5B the previous quarter. Its ten largest holdings account for 77% of the portfolio.
HBK Investments withdrew a net $3.69B in Q3 2021, closing 249 positions and reducing 210 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.21B position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 4.8% of assets, up from 4.4% a quarter earlier, followed by Technology and Financials.
Against the trend, HBK Investments opened a new position in Stamps.com, Inc. worth $277M.
- HBK Investments's largest Q3 2021 buy was Stamps.com, Inc.: 840,638 shares worth $277M.
- HBK Investments added most to Kansas City Southern in Q3 2021, an estimated $418M increase.
- HBK Investments's biggest Q3 2021 reduction was Xilinx Inc, cutting an estimated $125M.
- HBK Investments fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.21B.
- HBK Investments's ten largest holdings make up 77% of its $25.7B portfolio in Q3 2021.
- HBK Investments opened 172 new positions and closed 249 in Q3 2021.
- HBK Investments's portfolio value fell 9.9% quarter-over-quarter to $25.7B.
Based on HBK Investments's 13F filing for Q3 2021, filed 15 Nov 2021.